Full Press Release Details
BOSTON, May 11, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the following upcoming investor conferences:
Citi Biotech Virtual Co-Panel Day
º ‘Mood Disorders/Mental Health’ panel on Wednesday, May 18, 2022 at 11:00 a.m. ET
º ‘Movement Disorders/Epilepsy’ panel on Wednesday, May 18, 2022 at 3:30 p.m. ET
H.C. Wainwright Global Investment Conference
º Company presentation available on Tuesday, May 24, 2022 at 7:00 a.m. ET
The events will be available via webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. Replays of the webcasts will be available for 90 days following the event.
Tags
praxis precision medicines